Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc.（AUPH）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AUPH · 截至 2026年6月8日
活动摘要
买入笔数
14
P-Purchase only
卖出笔数
1
近12个月
买卖比
14.00
Buy/Sell (by trades)
整体情绪
Aurinia Pharmaceuticals Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AUPH 季度内部人买卖趋势
AUPH 内幕交易卖出 · AUPH 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AUPH CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AUPH 高管卖出股份 · AUPH 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 18, 2026 | Robertson Stephen P. Chief Legal Officer | Award | 115,541 | — | Form 4 |
| May 18, 2026 | Hearne Michael S CFO | Award | 116,144 | — | Form 4 |
| May 18, 2026 | Cole Ryan COO | Award | 116,144 | — | Form 4 |
| Mar 6, 2026 | Keenan Greg SVP, Chief Medical Officer | Other | 8,069 | $116K | Form 4 |
| Feb 27, 2026 | Miller Joseph M CFO | Award | 57,229 | — | Form 4 |
| Mar 2, 2026 | Miller Joseph M CFO | Other | 37,511 | $533K | Form 4 |
| Feb 27, 2026 | Donley Matthew Maxwell COO | Award | 58,160 | — | Form 4 |
| Mar 2, 2026 | Donley Matthew Maxwell COO | Other | 40,761 | $579K | Form 4 |
| Feb 27, 2026 | Greenleaf Peter CEO · Director | Award | 196,403 | — | Form 4 |
| Mar 2, 2026 | Greenleaf Peter CEO · Director | Other | 100,890 | $1.43M⚡ | Form 4 |
| Feb 27, 2026 | Keenan Greg SVP, Chief Medical Officer | Award | 40,586 | — | Form 4 |
| Feb 27, 2026 | Robertson Stephen P. EVP, General Counsel | Award | 59,090 | — | Form 4 |
| Mar 2, 2026 | Robertson Stephen P. EVP, General Counsel | Other | 36,525 | $519K | Form 4 |
| Feb 20, 2026 | Donley Matthew Maxwell COO | Other | 32,901 | $474K | Form 4 |
| Feb 20, 2026 | Greenleaf Peter CEO · Director | Other | 100,171 | $1.44M⚡ | Form 4 |
| Feb 20, 2026 | Miller Joseph M CFO | Other | 32,424 | $467K | Form 4 |
| Feb 20, 2026 | Robertson Stephen P. EVP, General Counsel | Other | 34,638 | $499K | Form 4 |
| Feb 2, 2026 | Keenan Greg SVP, Chief Medical Officer | Other | 11,552 | $168K | Form 4 |
| Jan 2, 2026 | Robertson Stephen P. EVP, General Counsel | Award | 48,558 | — | Form 4 |
| Jan 2, 2026 | Robertson Stephen P. EVP, General Counsel | Other | 40,385 | $644K | Form 4 |
| Jan 2, 2026 | Donley Matthew Maxwell COO | Award | 54,166 | — | Form 4 |
| Jan 2, 2026 | Donley Matthew Maxwell COO | Other | 42,787 | $682K | Form 4 |
| Jan 2, 2026 | Miller Joseph M CFO | Award | 49,038 | — | Form 4 |
| Jan 2, 2026 | Miller Joseph M CFO | Other | 40,161 | $641K | Form 4 |
| Jan 2, 2026 | Greenleaf Peter CEO · Director | Award | 165,384 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AUPH 内幕交易
AUPH 内幕交易
Aurinia Pharmaceuticals Inc.（AUPH）内幕交易数据来源于公司内部人（包括Robertson Stephen P. (Chief Legal Officer), Miller Joseph M (CFO), Donley Matthew Maxwell (COO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。AUPH内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Aurinia Pharmaceuticals Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AUPH 内幕交易 · 5个问题Aurinia Pharmaceuticals Inc.（AUPH）的内部人包括高管和董事，如Robertson Stephen P. (Chief Legal Officer), Miller Joseph M (CFO), Donley Matthew Maxwell (COO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026